HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention

Canadian Journal of Infectious Diseases

Volumn 15, Issue 4, 2004, Pages 221-225

  De, Prithwish ^a,c   Connor, Nancy ^b   Bouchard, Françoise ^b   Sutherland, Donald ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Health Services Branch   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Canada; Hepatitis C; HIV; Injection drug use; Prison; Testing

Indexed keywords

ADULT; ARTICLE; CANADA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COUNSELING; PREVALENCE; PREVENTIVE MEDICINE; PRISON; PRISONER; REINFORCEMENT; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE;

EID: 4644239199     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/695483     Document Type: Article

References (25)

1. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: A review. Clin Infect Dis 2002;35:305-12.
2. Rotily M, Weilandt C, Bird SM, et al. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health 2001;11:243-50.
3. Long J, Allwright S, Barry J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: A national cross sectional survey. BMJ 2001;323:1209-13.
4. Crofts N, Stewart T, Hearne P, Ping XY, Breschkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995;310:285-8.
5. Power KG, Markova I, Rowlands A, McKee J, Anslow PJ, Killfedder C. Intravenous drug use and HIV transmission among inmates in Scottish prisons. Br J Addict 1992;87:37-45.
6. Miranda AE, Vargas PM, St Louis ME, Viana MC. Sexually transmitted diseases among female prisoners in Brazil: Prevalence and risk factors. Sex Transm Dis 2000;27:491-5.
7. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: A national survey. Commun Dis Public Health 2000;3:121-6.
8. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993;12:673-6.
9. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction 2000;95:1207-16.
10. O'Sullivan BG, Levy MH, Dolan KA, et al. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. Med J Aust 2003;178:546-9.
11. Geduld J, Archibald CP. National trends of AIDS and HIV in Canada. Can Commun Dis Rep 2000;26:193-201.
12. Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 2000;14:575-80.
13. Calzavara LM, Burchell AN, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003;98:1257-65.
14. Guimaraes T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallas EG. High prevalence of hepatitis C infection in a Brazilian prison: Identification of risk factors for infection. Braz J Infect Dis 2001;5:111-8.
15. Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. QJM 2000;93:113-9.
16. Hankins C, Gendron S, Richard C, O'Shaughnessy M. HIV-1 infection in a medium security prison for women - Quebec. Can Dis Wkly Rep 1989;15:168-70.
17. Ford PM, White C, Kaufmann H, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995;153:I605-9.
18. Prefontaine RG, Chaudhary RK, Mathias RG. Analysis of risk factors associated with hepatitis B and C infection in correctional institutions in British Columbia. Can J Infect Dis 1994;5:153-6.
19. Calzavara LM, Major C, Myers T, et al. The prevalence of HIV-1 infection among inmates in Ontario, Canada. Can J Public Health 1995;86:335-9.
20. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ 1994;151:781-87.
21. Dufour A, Alary M, Poulin C, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10:1009-15.
22. Macalino GE, Hou JC, Kumar MS, Taylor LE, Sumantera IG, Rich JD. Hepatitis C infection and incarcerated populations. Int J Drug Policy 2004;15:103-14.
23. Heintges T, Wands JR. Hepatitis C virus: Epidemiology and transmission. Hepatology 1997;26:521-6.
24. Behrendt C, Kendig N, Dambita C, Herman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol 1994;139:918-26.
25. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: A review of international research and development. Addiction 2003;98:153-8.